A blog by Stefan Oschmann, EFPIA President, Chairman of the Executive Board and CEO of Merck
Europe has made great progress in healthcare in recent years. An EU citizen born today can expect to live 30 years longer than his or her ancestors a century ago. And much suggests that this trend will persist. From immuno-oncology to gene and cell therapy, we are seeing new medicines that give hope to patients who until recently have had no treatment options.
I am convinced that there has never been a more promising time for pharmaceutical innovation. Thanks to the digital revolution and new biotechnologies, we now have tools at our disposal that we would not have dared to dream about just a few years ago.
Read more
Protect The Spark
Every new treatment or cure starts with the spark of an idea. That spark has to be nurtured and cared for through the...
Read more
For The Chance To...
Millions of people wouldn't be here today if it wasn't for life-changing science. And many more wouldn't be living the...
Read more
Taking place in February to mark the occasion of Rare Disease Day, this event celebrates the inspirational qualities...
Read more
About the EFPIA newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.